Buckman; Brad
Patent Applications and Registrations
Patent applications and USPTO patent grants for Buckman; Brad.The latest application filed is for "novel macrocyclic inhibitors of hepatitis c virus replication".
- Buckman; Brad - Oakland CA
- Buckman; Brad - US
| Patent | Date |
|---|---|
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20120251493 - Seiwert; Scott D. ; et al. | 2012-10-04 |
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20120101032 - BUCKMAN; Brad ; et al. | 2012-04-26 |
| Novel Inhibitors Of Hepatitis C Virus Replication App 20120094897 - Buckman; Brad ; et al. | 2012-04-19 |
| Substituted Proline Inhibitors Of Hepatitis C Virus Replication App 20120095211 - Buckman; Brad ; et al. | 2012-04-19 |
| Plasma Carboxypeptidase B Inhibitors App 20110319366 - Buckman; Brad ; et al. | 2011-12-29 |
| Novel Inhibitors Of Hepatitis C Virus Replication App 20110312996 - Buckman; Brad ; et al. | 2011-12-22 |
| Macrocyclic inhibitors of hepatitis C virus replication Grant 8,048,862 - Seiwert , et al. November 1, 2 | 2011-11-01 |
| Novel Inhibitors Of Hepatitis C Virus Replication App 20110152246 - Buckman; Brad ; et al. | 2011-06-23 |
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20110129444 - BUCKMAN; BRAD ; et al. | 2011-06-02 |
| Novel Inhibitors of Hepatitis C Virus Replication App 20110110890 - Beigelman; Leonid ; et al. | 2011-05-12 |
| Peptide inhibitors of hepatitis C virus replication Grant 7,932,277 - Seiwert , et al. April 26, 2 | 2011-04-26 |
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20110081315 - Buckman; Brad ; et al. | 2011-04-07 |
| Therapeutic Antiviral Peptides App 20110082182 - Buckman; Brad ; et al. | 2011-04-07 |
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20110059047 - Seiwert; Scott D. ; et al. | 2011-03-10 |
| Therapeutic Antiviral Peptides App 20100119479 - BUCKMAN; BRAD ; et al. | 2010-05-13 |
| Novel Peptide Inhibitors Of Hepatitis C Virus Replication App 20090297476 - SEIWERT; SCOTT ; et al. | 2009-12-03 |
| Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20090269305 - Seiwert; Scott D. ; et al. | 2009-10-29 |
| Plasma carboxypeptidase B inhibitors Grant 7,528,173 - Buckman , et al. May 5, 2 | 2009-05-05 |
| Plasma Carboxypeptidase B Inhibitors App 20090093520 - BUCKMAN; Brad ; et al. | 2009-04-09 |
| Novel Inhibitors Of Hepatitis C Virus Replication App 20090047246 - Beigelman; Leonid ; et al. | 2009-02-19 |
| Plasma carboxypeptidase b inhibitors App 20060247213 - Buckman; Brad ; et al. | 2006-11-02 |
| Use of TAFI inhibitors for enhanced myocardial reperfusion and facilitated PCI App 20060234986 - Buckman; Brad ; et al. | 2006-10-19 |
| Platelet adenosine diphosphate receptor antagonists Grant 7,084,142 - Bryant , et al. August 1, 2 | 2006-08-01 |
| Platelet adenosine diphosphate receptor antagonists App 20060122188 - Bryant; Judi ; et al. | 2006-06-08 |
| Platelet adenosine diphosphate receptor antagonists Grant 7,056,923 - Bryant , et al. June 6, 2 | 2006-06-06 |
| Platelet adenosine diphosphate receptor antagonists App 20040138229 - Bryant, Judi ; et al. | 2004-07-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 